4//SEC Filing
Morenstein Scott D 4
Accession 0000919574-19-007463
CIK 0001183765other
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 4:24 PM ET
Size
10.8 KB
Accession
0000919574-19-007463
Insider Transaction Report
Form 4
CAXTON CORP
Director
Transactions
- Purchase
Common Stock
2019-11-21$8.00/sh+468,750$3,750,000→ 2,052,991 total(indirect: See Footnote)
Kovner Bruce
Director
Transactions
- Purchase
Common Stock
2019-11-21$8.00/sh+468,750$3,750,000→ 2,052,991 total(indirect: See Footnote)
Morenstein Scott D
Director
Transactions
- Purchase
Common Stock
2019-11-21$8.00/sh+468,750$3,750,000→ 2,052,991 total(indirect: See Footnote)
CDK ASSOCIATES, L.L.C.
Director
Transactions
- Purchase
Common Stock
2019-11-21$8.00/sh+468,750$3,750,000→ 2,052,991 total(indirect: See Footnote)
Footnotes (2)
- [F1]These shares are owned directly by CDK Associates, LLC, which is a reporting person, and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation; and (iii) Scott Morenstein, a Managing Director of the investment manager of CDK Associates, LLC.
- [F2]Scott Morenstein serves as a director of the Issuer. Caxton Corporation, Bruce Kovner and CDK Associates, L.L.C. may be considered directors by deputization due to their affiliation with Scott Morenstein. Each Reporting Person disclaims beneficial ownership of these shares except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Molecular Templates, Inc.
CIK 0001183765
Entity typeother
Related Parties
1- filerCIK 0001576113
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 4:24 PM ET
- Size
- 10.8 KB